Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke
NCT02460484Phase 2Withdrawn
- Start
- Apr 2015
- Primary completion
- Jun 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous umbilical cord blood in perinatal arterial ischemic stroke (PAIS). Planned start Apr 2015; status: withdrawn.
02
Drugs
autologous umbilical cord blood
03
Conditions
perinatal arterial ischemic stroke (PAIS)
Beyond the preview
Go deeper on NCT02460484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460484.